Suchergebnisse - "Bajaj, Jasmohan S"

PubPharm (19)

1

The RIVET RCT : Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy

enthalten in: Hepatology communications | 2024

von Bajaj, J. | Fagan, A. | Gavis, E. | +11

2

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis : 2 Randomized, Placebo-controlled Trials

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Bajaj, J. | Hassanein, T. | Pyrsopoulos, N. | +5

3

A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy : HEAL study

enthalten in: Journal of hepatology | 2023

von Fagan, A. | Gavis, E. | Gallagher, M. | +15

CommentIn: J Hepatol. 2023 Mar;78(3):e96-e97. - PMID 36216135

4

Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers

enthalten in: Hepatology communications | 2023

von Shaw, J. | Acharya, C. | Albhaisi, S. | +9

CommentIn: Hepatol Commun. 2023 May 4;7(5):. - PMID 37141502

5

Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice

enthalten in: Nature communications | 2022

von Wolstenholme, J. | Saunders, J. | Smith, M. | +17

6

Pharmacokinetics/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes

enthalten in: Clinical and translational science | 2022

von Safadi, R. | Rahimi, R. | Thabut, D. | +8

7

Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Rahimi, R. | Safadi, R. | Thabut, D. | +5

CommentIn: Clin Gastroenterol Hepatol. 2020 Nov 3;:null. - PMID 33157316

8

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes : Analysis of Two Trials

enthalten in: Hepatology communications | 2021

von Bajaj, J. | Shamsaddini, A. | Fagan, A. | +7

9

Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis

enthalten in: JCI insight | 2019

von Bajaj, J. | Salzman, N. | Acharya, C. | +27

10

Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy : A Phase 1, Randomized, Placebo-Controlled Trial

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Bajaj, J. | Salzman, N. | Acharya, C. | +14

ErratumIn: Hepatology. 2020 Oct;72(4):1501. - PMID 33464567